Utilization Patterns of Pulmicort in Real Life Practice

The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated factors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Behavior Bronchial Diseases Health Behavior Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Patient Acceptance of Health Care Respiratory Hypersensitivity Respiratory Tract Diseases Treatment Adherence and Compliance

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Barcelona, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion
Patients previously treated with Pulmicort CFC who have changed their treatment to Pulmicort HFA

Exclusion criteria

Disability that, from investigator point of view, prevent from complying the follow up schedule
To have participated in any clinical study in the past 6 months

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Utilization Patterns of Pulmicort HFA in Real Life Practice

Important dates

Study start: 2008
Study completion: 2009
First posted: Apr 17, 2008
Registry last updated: Dec 1, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed